Lastly, we identified RTL1 as a candidate marker for tumors with unfavorable prognosis due to loss of imprinting of the maternal allele, similar to earlier reports on loss of imprinting of the IGF2 gene in Wilms’ tumors.89 This evidence concerns the gene RTL1 and Nephroblastoma.